Clearance Summary
SENDX 100 PH, BLOOD GAS & ELECTROLYTE ANALYSIS SYSTEM received FDA 510(k) clearance under submission number K954482, sponsored by Cirrus Medical,Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1995-12-04.
- Submission: K954482
- Applicant / Sponsor: Cirrus Medical,Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1120
- Decision date: 1995-12-04
Classification & Regulation
This clearance is catalogued under FDA product code CHL and 21 CFR 862.1120, within the Clinical Chemistry review panel as a Class II device.